These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 7807995

  • 1. VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line.
    Vellenga E, Asschert L, Withoff S, van der Kolk D, de Vries EG.
    Leukemia; 1994 Dec; 8(12):2060-4. PubMed ID: 7807995
    [Abstract] [Full Text] [Related]

  • 2. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T, An T, Zwelling LA, Takano H, Fojo AT, Kleinerman ES.
    Oncol Res; 1996 Dec; 8(3):101-10. PubMed ID: 8823806
    [Abstract] [Full Text] [Related]

  • 3. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 4. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K, Nakamura T, Ono M, Kusano T, Okada K, Kikuchi A, Adachi N, Kohno K, Higashi K, Kuwano M.
    Oncol Res; 1996 Feb 15; 8(5):197-206. PubMed ID: 8884812
    [Abstract] [Full Text] [Related]

  • 5. Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells.
    Towatari M, Ito Y, Morishita Y, Tanimoto M, Kawashima K, Morishima Y, Andoh T, Saito H.
    Cancer Res; 1990 Nov 15; 50(22):7198-202. PubMed ID: 1699657
    [Abstract] [Full Text] [Related]

  • 6. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
    Mirski SE, Evans CD, Almquist KC, Slovak ML, Cole SP.
    Cancer Res; 1993 Oct 15; 53(20):4866-73. PubMed ID: 8104687
    [Abstract] [Full Text] [Related]

  • 7. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 8. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE, Cadena RS, Raimondi SC, Beck WT.
    Mol Pharmacol; 2000 Feb 01; 57(2):296-307. PubMed ID: 10648639
    [Abstract] [Full Text] [Related]

  • 9. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E.
    Leukemia; 1995 Jun 01; 9(6):1013-24. PubMed ID: 7596166
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ, White RL, Matsunami N, Neufeld KL.
    Cancer Res; 2000 Dec 15; 60(24):6989-94. PubMed ID: 11156401
    [Abstract] [Full Text] [Related]

  • 11. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R, Constantinou A, Kamath N, Dubyak G, Grabowski D, Krivacic K.
    Mol Pharmacol; 1996 Aug 15; 50(2):243-8. PubMed ID: 8700130
    [Abstract] [Full Text] [Related]

  • 12. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 13. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
    Wang SJ, Peyrollier K, Bourguignon LY.
    Arch Otolaryngol Head Neck Surg; 2007 Mar 15; 133(3):281-8. PubMed ID: 17372087
    [Abstract] [Full Text] [Related]

  • 14. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ, Fisher MH, Stephenson J, Li DH, Zhou BS, Cheng YC.
    Cancer Res; 1988 Nov 01; 48(21):5956-64. PubMed ID: 2844393
    [Abstract] [Full Text] [Related]

  • 15. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N, Belldegrun A, Bonavida B.
    Cancer Res; 1995 Oct 15; 55(20):4633-9. PubMed ID: 7553641
    [Abstract] [Full Text] [Related]

  • 16. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
    Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC.
    Mol Pharmacol; 1994 Oct 15; 46(4):605-11. PubMed ID: 7969039
    [Abstract] [Full Text] [Related]

  • 17. Hyperthermia can reduce cytotoxicity from etoposide without a corresponding reduction in the number of topoisomerase II-DNA cleavable complexes.
    Dynlacht JR, Wong RS, Albright N, Dewey WC.
    Cancer Res; 1994 Aug 01; 54(15):4129-37. PubMed ID: 8033146
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G, Cazzola M, Rosti V, Carlo-Stella C, Santini V, Ponchio L, Peverali FA, Della Valle G, Rossi Ferrini P, Ascari E.
    Leukemia; 1991 Oct 01; 5(10):886-91. PubMed ID: 1961022
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
    Eliot HE, Borner MM, Sinha BK.
    Anticancer Res; 1995 Oct 01; 15(3):729-33. PubMed ID: 7645949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.